Altria Group, Inc. (VIE:ALTR)

Checkpoint Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	1,287	3,127	3,686	4,030	4,544	4,945
Cash & Short-Term Investments	1,287	3,127	3,686	4,030	4,544	4,945
Cash Growth	-28.46%	-15.17%	-8.54%	-11.31%	-8.11%	133.59%
Accounts Receivable	241	177	71	1,721	-	137
Other Receivables	-	93	496	151	47	-
Receivables	241	270	567	1,872	47	137
Inventory	1,016	1,080	1,215	1,180	1,194	1,966
Restricted Cash	9	8	5	15	-	1
Other Current Assets	79	28	112	123	298	68
Total Current Assets	2,632	4,513	5,585	7,220	6,083	7,117
Property, Plant & Equipment	1,610	1,617	1,652	1,608	1,553	2,012
Long-Term Investments	8,143	8,195	10,011	9,600	13,481	19,529
Goodwill	6,072	6,945	6,791	5,177	5,177	5,177
Other Intangible Assets	12,900	12,973	13,686	12,384	12,306	12,615
Other Long-Term Assets	975	934	845	965	923	964
Total Assets	32,332	35,177	38,570	36,954	39,523	47,414
Accounts Payable	569	700	582	552	449	380
Accrued Expenses	2,329	2,468	2,618	1,646	1,651	1,620
Current Portion of Long-Term Debt	1,069	1,527	1,121	1,556	1,105	1,500
Current Unearned Revenue	-	-	2,700	252	287	301
Other Current Liabilities	2,821	4,086	4,298	4,610	5,087	5,262
Total Current Liabilities	6,788	8,781	11,319	8,616	8,579	9,063
Long-Term Debt	23,651	23,399	25,112	25,124	26,939	27,971
Long-Term Unearned Revenue	-	-	-	2,700	-	-
Long-Term Deferred Tax Liabilities	3,661	3,749	2,799	2,897	3,692	4,532
Other Long-Term Liabilities	370	365	1,621	324	283	381
Total Liabilities	35,538	37,365	42,060	40,877	41,129	44,449
Common Stock	935	935	935	935	935	935
Additional Paid-In Capital	5,895	5,905	5,906	5,887	5,857	5,910
Retained Earnings	35,525	35,516	31,094	29,792	30,664	34,679
Treasury Stock	-42,780	-42,194	-38,802	-37,816	-36,006	-34,344
Comprehensive Income & Other	-2,831	-2,400	-2,673	-2,771	-3,056	-4,341
Total Common Equity	-3,256	-2,238	-3,540	-3,973	-1,606	2,839
Minority Interest	50	50	50	50	-	126
Shareholders' Equity	-3,206	-2,188	-3,490	-3,923	-1,606	2,965
Total Liabilities & Equity	32,332	35,177	38,570	36,954	39,523	47,414
Total Debt	24,720	24,926	26,233	26,680	28,044	29,471
Net Cash (Debt)	-23,433	-21,799	-22,547	-22,650	-23,500	-24,526
Net Cash Per Share	-13.85	-12.69	-12.69	-12.56	-12.74	-13.19
Filing Date Shares Outstanding	1,680	1,691	1,763	1,786	1,817	1,859
Total Common Shares Outstanding	1,681	1,691	1,763	1,786	1,823	1,858
Working Capital	-4,156	-4,268	-5,734	-1,396	-2,496	-1,946
Book Value Per Share	-1.94	-1.32	-2.01	-2.23	-0.88	1.53
Tangible Book Value	-22,228	-22,156	-24,017	-21,534	-19,089	-14,953
Tangible Book Value Per Share	-13.22	-13.11	-13.62	-12.06	-10.47	-8.05
Land	-	124	123	123	123	348
Buildings	-	1,552	1,535	1,478	1,422	1,480
Machinery	-	2,662	2,684	2,578	2,652	3,010
Construction In Progress	-	199	240	248	235	312

Updated Feb 26, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.